Nutrition

Thursday 1 July 2021 - Updated on Monday 15 November 2021
Find out about current projects on malnutrition.

Reduced follow-up

In January 2018, we initiated a cluster randomized trial to assess the effectiveness of monthly vs. standard weekly follow up in the treatment of uncomplicated severe acute malnutrition in children 6 to 59 months of age. This study was conducted as a stratified cluster randomized trial. The unit of randomization was the outpatient therapeutic feeding center. The 10 health centers were stratified by size, and centers within a stratum were randomized in a 1:1 ratio to one of two schedules of treatment: (1) standard weekly visits or (2) monthly visits with support for home-based surveillance. Distribution of the therapeutic feeding rations, as well as medical and anthropometric surveillance, took place on a weekly or monthly basis until discharge according to the random assignment of the site. Caregivers in the monthly visit group received additional instruction at admission regarding home-based MUAC measurement and clinical surveillance. The study "Reducing the frequency of follow up and task sharing in the treatment of uncomplicated severe acute malnutrition" aimed to strengthen the evidence base for more flexible ways to deliver nutritional treatment in access-limited and high-burden settings.

 

Objective

The study aims to estimate the effectiveness of monthly vs. standard weekly follow up in the treatment of uncomplicated severe acute malnutrition in children aged 6 to 59 months in terms of nutritional recovery.

Methodology

A stratified cluster randomized trial. The 10 health centers are stratified by size, and centers within a stratum will be randomized in a 1:1 ratio to one of two schedules of treatment: (1) standard weekly visits (2) monthly visits with support for home-based surveillance.

Who’s involved besides MSF?

Children's Investment Fund Foundation (CIFF), Sokoto State Nutrition Team, UNICEF Nigeria, MSF-OCA, Harvard School of Public Health

Country

Nigeria

Tentative End date

May 2021

Our Role

PI, Scientific Oversight, Implementation

 

For more information contact: Sheila Isanaka